As of May 22
| +0.03 / +0.48%|
The 5 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +41.96% increase from the last price of 6.34.
The current consensus among 5 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.